CEL-SCI Receives Regulatory Clearance to Expand Its Phase III Head and Neck Cancer Trial into Romania
January 26, 2015 at 09:00 AM EST
CEL-SCI Corporation (NYSE MKT: CVM) today announced the Romanian Ministry of Health has cleared the Company to begin patient enrollment ...